Can an Immune-Modulating drug clear Alzheimer's brain plaques?
NCT ID NCT06862960
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This phase 2 trial investigates whether ozanimod, an oral drug that regulates the immune system, can reduce brain amyloid plaques and inflammation in people with moderate Alzheimer's disease. Forty participants aged 55 to 80 will receive either ozanimod or standard Alzheimer's medications for 27 weeks. The study uses brain scans and blood tests to measure changes in amyloid burden and neuroinflammation, comparing the two groups.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ozanimod, an oral drug that modulates the immune system by targeting sphingosine-1-phosphate receptors
- What this could lead to
- If successful, this could point toward a new treatment approach for Alzheimer's disease that targets inflammation and amyloid buildup in the brain.
- What could go wrong
- This is an early proof-of-concept study with only 40 participants, so results may not apply broadly. Ozanimod is already approved for other conditions, but its effects on Alzheimer's are unknown, and side effects like heart rate changes or infections are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fujian Medical University Union Hospital
RECRUITINGFuzhou, Fujian, 350001, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Could your heart hold the key to Alzheimer's prevention?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can a Voice-Based app map healthy brain aging across 80 years?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can brain scans and gut bacteria reveal Alzheimer's secrets?